Renegade Bio
Berkeley · Founded 2020 · $330K raised
- Headquarters
- Berkeley
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- renegade.bio
- Total Funding
- $330K
- Last Round
- $330K Series AMar 2023
- Rounds
- 2
About
Renegade Bio was a Berkeley, California-based public benefit corporation providing COVID-19 diagnostic testing services for businesses, schools, and communities. Founded in 2020 by Craig Rouskey, it operated its own CLIA- and CAP-certified lab and developed novel diagnostics leveraging PCR, NGS, and LCMS capabilities. The company closed in March 2024 after four years of operation.
Summary
Renegade Bio is a Biotech company based in Berkeley, founded in 2020. It has raised $330K in total across 2 rounds, most recently a $330K Series A round in Mar 2023. Investors include Anzu Partners, FinRebel and SOSV.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...